DEZHAN HEALTHCARE(SZ:000813) Xin Lang Cai Jing·2025-08-23 02:14Core Viewpoint - 德展健康 reported a significant decline in both revenue and net profit for the first half of 2025, indicating financial challenges faced by the company [1][3]. Financial Performance - The company's total revenue for the first half of 2025 was 166 million yuan, a decrease of 81.96 million yuan compared to the same period last year, representing a year-on-year decline of 33.01% [1]. - The net profit attributable to shareholders was -42.93 million yuan, a decrease of 53.08 million yuan from the same period last year, reflecting a year-on-year decline of 522.81% [1]. - Operating cash flow showed a net inflow of 27.80 million yuan, an increase of 38.09 million yuan compared to the same period last year [1]. Profitability and Efficiency Metrics - The latest asset-liability ratio stood at 4.97%, an increase of 0.86 percentage points from the previous quarter and an increase of 2.41 percentage points from the same period last year [3]. - The gross profit margin was 54.75%, down by 5.07 percentage points from the previous quarter and down by 6.02 percentage points from the same period last year [3]. - Return on equity (ROE) was -0.86%, a decrease of 1.05 percentage points compared to the same period last year [3]. - The diluted earnings per share were -0.02 yuan, a decrease of 0.02 yuan from the same period last year, reflecting a year-on-year decline of 527.66% [3]. - The total asset turnover ratio was 0.03 times, a decrease of 0.01 times from the same period last year, representing a year-on-year decline of 32.03% [3]. - The inventory turnover ratio was 0.37 times, a decrease of 0.10 times from the same period last year, indicating a year-on-year decline of 21.53% [3]. Shareholder Structure - The number of shareholders was 58,300, with the top ten shareholders holding a total of 1.079 billion shares, accounting for 49.82% of the total share capital [3]. - The largest shareholder is 新疆凯迪投资有限责任公司 with a holding of 18.90% [3].